https://doi.org/10.4081/mem.2001.728
The most recent progresses in international and Italian legislations on bioethical evaluation of clinical studies.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Following a brief historical excursus of the legislation concerning pharmaceutical products which has been adopted in the European Union and acknowledged by Italy, this paper describes more recent legislation for evaluating the ethical review of clinical trials (drug studies conducted on humans subjects after completion of drug testing on animals). In particular, the Author takes into account the new European regulations of Good Clinical Practice (GCP) and the impulse that they have given to the legislation in Italy with regards to the "informed consent" and the constitution and the role of the Ethics Committees. Moreover, the further developments of Italian legislation are discussed. This paper is so a review of this topic. Certainly, at present, in Italy, many progresses have been achieved in the transposition of the Communitary law into the National rights especially in the field of the clinical experimentation on human subjects, but some more work should be performed to cover wider needs in many other fields of the scientific research in general.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.